March 2011 — A label change was required by the FDA to include data supporting use for individuals from the ages of 50-59. Reference: Center for Biologics Evaluation and Research. “Approved Products – Zostavax.” Internet Archive Wayback Machine, Center for Biologics Evaluation and Research, wayback.archive-it.org/7993/20170722150959/https:/www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm136941.htm.
Continue Reading2011 — A study published in JAMA Ophthalmology reveals that Zostavax vaccine likely leads to retinal necrosis. References: Center for Biologics Evaluation and Research. “Approved Products – Zostavax.” Internet Archive Wayback Machine, Center for Biologics Evaluation and Research, wayback.archive-it.org/7993/20170722150959/https:/www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm136941.htm. Charkoudian, Leon D. “Acute Retinal Necrosis After Herpes Zoster Vaccination.” Archives of Ophthalmology, JAMA Network, 1 Nov. 2011, jamanetwork.com/journals/jamaophthalmology/fullarticle/1106674.
Continue ReadingDecember 2010 – A release of documents from the Sanofi-funded GEICAM 9805 study revealed that around 9.2% of patients suffered hair loss that lasted more than a decade. Reference: “Taxotere Lawsuit – Permanent Hair Loss and Illegal Marketing.” Drugwatch.com, 20 Apr. 2020, www.drugwatch.com/taxotere/lawsuits/
Continue Reading2010 — A 50-year-old woman endured the worsening of her keratitis after being vaccinated with Zostavax. References: Zostavax.” Internet Archive Wayback Machine, Center for Biologics Evaluation and Research, wayback.archive-it.org/7993/20170722150959/https:/www.fda.gov/BiologicsBloodvaccines/Vaccines/ApprovedProducts/ucm136941.htm. Khalifa, Yousuf M. “Exacerbation of Zoster Interstitial Keratitis After Zoster Vaccination in an Adult.” Archives of Ophthalmology, JAMA Network, 1 Aug. 2010, www.jamanetwork.com/journals/jamaophthalmology/fullarticle/426103.
Continue Reading2008 — Researchers concluded that glyphosate exposure doubled a person’s chances of developing non-Hodgkin’s lymphoma in 2008 following a study of Swedish citizens who were exposed to a number of pesticides. Reference: Moncivais, Katy. “Roundup Cancer Lawsuit: 2020 Updates & Settlements.” Consumer Safety, 8 Jan. 2021, https://www.consumersafety.org/product-lawsuits/roundup/.
Continue Reading2007 — Roundup became the most used herbicide in the U.S. by 2007. The result of Roundup’s rising popularity was Roundup Ready crops, which began hitting the market in the late 1990s. From the introduction of Roundup Ready crops through 2016, the global glyphosate usage increased by more than 15 times. The U.S. made up 72% of the usage...
Continue Reading2007: The Food and Drug Administration first raised concern about incretin mimetics in 2007. They warned that incretin mimetics, especially exenatide (Byetta and Byuderon) and sitagliptin (Janumet and Januvia), could cause pancreatic diseases. The warning followed reports that a rising number of incretin mimetics users were being diagnosed with acute pancreatitis and pancreatic cancer. Reference: “FDA Investigating Reports of...
Continue ReadingDecember 2006 – A study conducted by the Rock Mountain Cancer Centers found that Taxotere caused 6% of women to suffer permanent alopecia. Reference: “Taxotere Lawsuit – Permanent Hair Loss and Illegal Marketing.” Drugwatch.com, 20 Apr. 2020, www.drugwatch.com/taxotere/lawsuits/
Continue ReadingOctober 2006 — Taxotere was approved for use in combination with cisplatin and fluorouracil for patients being treated for inoperable, locally advanced squamous cell carcinoma of the head and neck (SCCHN). Reference: “TAXOTERE® Receives U.S. FDA Approval for the Treatment of Patients with Head and Neck Cancer.” Sanofi, www.news.sanofi.us/press-releases?item=118381
Continue ReadingMay 2006 — Zostavax was approved by the FDA for patients 60 and older. Reference: Reference: Center for Biologics Evaluation and Research. “Zostavax.” U.S. Food and Drug Administration, FDA, www.fda.gov/vaccines-blood-biologics/vaccines/zostavax.
Continue Reading